Interestingly, it has been shown that IDO-mediated tryptophan degradation, by generating kynurenine, is able to induce tumor-promoting immunosuppressive Treg polarization of CD4+ T lymphocytes in vitro [99,103], a result in accordance with previously reported clinical data that IDO1 expression correlates with high FOXP3+ Treg expression in cancer patients [104,105]. The gene discussed is IDO1; the disease is neoplasm.